ENLIGHTEN HEALTH
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ENLIGHTEN HEALTH Trademark

Serial Number: 88581014

ENLIGHTEN HEALTH is a trademark filed by LABORATORY CORPORATION OF AMERICA HOLDINGS on August 15, 2019. The trademark is classified under Class 36 (Insurance & Financial), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

LABORATORY CORPORATION OF AMERICA HOLDINGS (347 trademarks)

531 SOUTH SPRING STREET
BURLINGTON, NC 27215

Entity Type: 03

Trademark Details

Filing Date

August 15, 2019

Registration Date

Not Registered

Published for Opposition

April 6, 2021

Goods & Services

Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs

Business consultancy, business management consultancy, business strategy advisory and marketing services for pharmaceutical, medical device, food and healthcare companies; business consulting services, business strategy advisory services and marketing services relating to the development, formulation and testing of pharmaceuticals, bio-technology products and medical devices; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of pharmaceutical products, bio-technological products or medical devices; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business organization consultancy; retail store and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel recruitment; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials or proof of concept trials; business consultation in the nature of design and development of market access strategies; implementation of market access strategies and processes on behalf of others for business purposes; business data analysis and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties for business cost analysis; business consultation services in the market authorization of drugs; commercial administration of the licensing of the goods and services of others; compilation of information into computer databases; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market research, marketing services, database management, and business project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business management services, namely, supply and demand forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; Business services provided to the health care industry, namely, consulting services, market intelligence, data collection, data submission and patient management; holding company services, namely, providing ownership cost analyses, financial control audits, and business information reporting services for subsidiaries and affiliates; holding company services, namely, providing business management and business administration services for subsidiaries and affiliates

Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 5, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 4, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2021 EXRA
SOU EXTENSION 1 GRANTED
Dec 1, 2021 EX1G
SOU EXTENSION 1 FILED
Dec 1, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 1, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 1, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
ASSIGNED TO LIE
Feb 17, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 5, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2019 NWOS
NEW APPLICATION ENTERED
Aug 19, 2019 NWAP